CClinicalTrials.gg
CompletedNCT04467372Updated Sep 9, 2021

Tart Cherry Supplementation & Gut Microbiome and Inflammation

An interventional study of Tart cherry juice concentrate and Juice placebo in Inflammation, Glucose Regulation and Sleep, sponsored by Ohio University. Completed at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-09-09.

Sponsored by Ohio University · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Mar 2019, registered Jun 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

There has been a rapid increase in researching the use of tart cherry supplements in the past 5 years, particularly for inflammatory conditions. Many formulations of cherry supplements exist, however there has been no comparison between these different types. This is particularly important in the realm of inflammation research because sugar is known to increase the inflammatory response. The pill form of cherry supplementation has no added sugar and is naturally low in sugar (\< 1g) while the juice form is higher from added sugar. Recent work indicates tart cherry consumption can change gut microbiota, which may modify inflammation. The purpose of this study is to look at the effects of taking a cherry supplement, either in capsule or juice form, on the gut microbiome, inflammation, and health-related variables such as blood pressure, glucose regulation and sleep quality.

Read the detailed description

Participants will consume a tart cherry or placebo product for 30 days and attend 5 visits in the Exercise Physiology Lab at Ohio University over the 30 day period. They will self-collect a stool sample at baseline, 14 days and 30 days after supplementation. Blood samples will be taken at baseline, 7 days, 14 days, and 30 days after supplementation. Throughout the study participates will rate symptoms (stomach, head, etc.), pain and sleep quality using an online survey for which the link will be emailed. Participants will maintain normal diet and exercise routine and to track these for the duration of the study.

02

Conditions studied

  • Inflammation
  • Glucose Regulation
  • Sleep

Browse trials for

03

In context

Inflammation

3,439 studies on the registry are indexed under Inflammation; 629 are open to participants now.

This study's enrollment of 70 is above the median of 50 across 2,437 interventional studies indexed under Inflammation.

Browse Inflammation studies →

Lead sponsor

Ohio University is the lead sponsor of 64 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 18-55 years old
  • participate in 150 minutes of exercise per week
  • non-smoker
  • have no known allergy to cherries or cherry juice
  • are not taking food supplements (turmeric/curcumin, cherry products, greens, etc.). -You must have access to the internet and be willing to record your food intake, physical activity and sleep quality/duration during the study.

Exclusion criteria

Exclusion Criteria:

  • not 18-55 years old.
  • have quit smoking less than one year ago.
  • have been diagnosed with a metabolic disorder such as diabetes, thyroid disorder, or high cholesterol.
  • are currently being treated for arthritis or an inflammatory condition, such as arthritis, gout, lupus or Sjogren's syndrome.
  • are currently being treated for cardiovascular disease, high blood pressure, fibromyalgia, or irritable bowel syndrome.
  • are pregnant.
  • regularly consume cherries or are allergic to cherries.
  • currently use anti-inflammatory medications.
  • have used corticosteroids in the last two months.
  • are not willing to follow a low polyphenol diet.
  • are not willing to have blood drawn on 4 occasions.
  • are not willing to provide a stool sample on 3 occasions.
  • do not have access to the internet.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    Tart cherry juice concentrate

    tart cherry juice

    Dietary Supplement: Tart cherry juice concentrate

  • Experimental
    Freeze dried tart cherry powder

    tart cherry capsules

    Dietary Supplement: Freeze dried tart cherry powder

  • Experimental
    Juice placebo

    kool-aid

    Dietary Supplement: Juice placebo

  • Experimental
    Capsule placebo

    maltodextrin

    Dietary Supplement: Capsule placebo

Interventions

  • Dietary supplementTart cherry juice concentrate

    Two 8oz bottles of tart cherry juice concentrate daily for 30 days

  • Dietary supplementJuice placebo

    Two 8oz bottles of placebo juice daily for 30 days

  • Dietary supplementFreeze dried tart cherry powder

    Two freeze dried tart cherry powder capsules daily for 30 days

  • Dietary supplementCapsule placebo

    Two placebo capsules daily for 30 days

06

What researchers measure

Primary outcomes

  1. Changes in inflammation measured via tumor necrosis factor alpha (pg/mL)

    Time frame: baseline, 7 days, 14 days, and 30 days post supplementation.

  2. Changes in inflammation measured via erythrocyte sedimentation rate (mm/hour)

    Time frame: baseline, 7 days, 14 days, and 30 days post supplementation.

  3. Changes in inflammation measured via c-reactive protein (mg/L) and uric acid (mg/dL).

    Time frame: baseline, 7 days, 14 days, and 30 days post supplementation.

  4. Changes in glucose regulation assessed via plasma glucose (mg/dL)

    Time frame: baseline, 7 days, 14 days, and 30 days post supplementation.

  5. Changes in glucose regulation assessed via insulin (mIU/L)

    Time frame: baseline, 7 days, 14 days, and 30 days post supplementation.

  6. Changes in glucose regulation assessed via glycated albumin (%).

    Time frame: baseline, 7 days, 14 days, and 30 days post supplementation.

  7. Changes in sleep quantity (hours and minutes) assessed via daily survey.

    Time frame: daily for 30 days

  8. Changes in sleep quality measured via 100mm visual analogue scale.

    Time frame: daily for 30 days

  9. Changes in gut microbiome bacterial counts

    Time frame: baseline, 14 days, and 30 days post supplementation.

07

Study locations

1 site
  • Ohio University Exercise Physiology Lab
    Athens, Ohio 45701, United States
08

References and documents

Publications

  • Hillman AR, Chrismas BCR. Thirty Days of Montmorency Tart Cherry Supplementation Has No Effect on Gut Microbiome Composition, Inflammation, or Glycemic Control in Healthy Adults. Front Nutr. 2021 Sep 16;8:733057. doi: 10.3389/fnut.2021.733057. eCollection 2021. PubMed 34604282 ↗

Individual participant data

Plan to share: No — Available by request

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 9, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04467372
Lead sponsor
Ohio University
Responsible party
Angela Hillman (Assistant Professor, Ohio University) — Principal investigator
First posted
Jul 13, 2020
Start date
Mar 18, 2019
Primary completion
Oct 16, 2019
Completion
Jul 1, 2021
Last update
Sep 9, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion